Early detection of Alzheimer's disease using PiB and FDG PET

Early detection of Alzheimer's disease using PiB and FDG PET

Use of biomarkers in the detection of early and preclinical Alzheimer's disease (AD) has become of central importance following publication of the NIA-Alzheimer's Association revised criteria for the diagnosis of AD, mild cognitive impairment (MCI) and preclinical AD. The use of in vivo am...

Full description

Bibliographic Details
Main Authors:	Ann D. Cohen, William E. Klunk
Format:	Article
Language:	English
Published:	Elsevier 2014-12-01
Series:	Neurobiology of Disease
Subjects:	Amyloid Glucose metabolism Alzheimer's disease Pittsburgh compound B FDG Neuroimaging
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996114001107

Similar Items

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
by: Robert Laforce, Jr, et al.
Published: (2014-01-01)

Postmortem Neocortical 3H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease
by: Violetta N. Pivtoraiko, et al.
Published: (2021-08-01)

Clinical Impact of PET With 18F-FDG and 11C-PIB in Patients With Dementia in a Developing Country
by: Andres Damian, et al.
Published: (2021-05-01)

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects
by: James M. Mountz, et al.
Published: (2015-01-01)

Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study
by: Qi Qin, et al.
Published: (2021-09-01)

PiB fails to map amyloid deposits in cerebral cortex of aged dogs with canine cognitive dysfunction
by: Rikke eFast, et al.
Published: (2013-12-01)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
by: Chetsadaporn Promteangtrong, et al.

Optimization of the k2′ Parameter Estimation for the Pharmacokinetic Modeling of Dynamic PIB PET Scans Using SRTM2
by: Débora E. Peretti, et al.
Published: (2019-12-01)

Correlação de imagens metabólicas (PET 18F-FDG) com imagens de fluxo sanguíneo (PET 11C-PIB) em idosos com queixa de memória
by: Carneiro, Camila de Godoi
Published: (2019)

Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study
by: Tomomichi Iizuka, et al.
Published: (2017-06-01)

In vivo Imaging With 18F-FDG- and 18F-Florbetaben-PET/MRI Detects Pathological Changes in the Brain of the Commonly Used 5XFAD Mouse Model of Alzheimer's Disease
by: Timon N. Franke, et al.
Published: (2020-09-01)

Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET
by: Suhong Kim, et al.
Published: (2021-06-01)

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
by: Virginia Pérez-Grijalba, et al.
Published: (2019-12-01)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
by: Youn YC, et al.
Published: (2017-06-01)

Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET
by: Xue-Yuan Li, et al.
Published: (2016-10-01)

Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases
by: Sonja Daerr, et al.
Published: (2017-01-01)

Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study
by: Larissa Helena Torres, et al.
Published: (2020-01-01)

Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors
by: Sadek A. Nehmeh, et al.
Published: (2021-04-01)

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
by: Paul Edison, et al.
Published: (2008-12-01)

18F-FDG-PET in Mouse Models of Alzheimer's Disease
by: Caroline Bouter, et al.
Published: (2019-04-01)

FDG PET and MRI as biomarkers of Tau pathology in Alzheimer’s disease
by: Ekaputri, Putu Ayuwidia
Published: (2021)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
by: Fedor Levin, et al.
Published: (2021-02-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
by: Shizuo Hatashita, et al.
Published: (2019-09-01)

Einfluss des Vigilanzniveaus während der [18F]FDG-PET-Untersuchung auf den regionalen zerebralen Glucosestoffwechsel
by: Günther, Thomas
Published: (2013)

Dynamic FDG PET Imaging to Probe for Cardiac Metabolic Remodeling in Adults Born Premature
by: Philip A. Corrado, et al.
Published: (2021-03-01)

A Novel Individual Metabolic Brain Network for 18F-FDG PET Imaging
by: Sheng-Yao Huang, et al.
Published: (2020-05-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications
by: Luiz Kobuti Ferreira, et al.
Published: (2011-01-01)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
by: Ya-Nan Ou, et al.
Published: (2019-06-01)

The Evolving Role of 18F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
by: Kai Shen, et al.
Published: (2021-07-01)

Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis
by: Débora E. Peretti, et al.
Published: (2021-01-01)

Diagnostic biomarkers in Alzheimer’s disease
by: Emerlee Andersen, et al.
Published: (2021-12-01)

Biomarkers of Alzheimer's disease
by: Rebecca Craig-Schapiro, et al.
Published: (2009-08-01)

Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort
by: Sang Won Seo, et al.
Published: (2017-01-01)

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
by: Eider M Arenaza-Urquijo, et al.
Published: (2015-08-01)

Enhanced glucose metabolism mediated by CD147 is associated with 18F‐FDG PET/CT imaging in lung adenocarcinoma
by: Yufan Zhang, et al.
Published: (2020-05-01)

Deep Learning based Classification of FDG-PET Data for Alzheimer's Disease
Published: (2017)

Integrated 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging (18F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay
by: Amarnath Jena, et al.
Published: (2015-10-01)

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
by: Chiara Villa, et al.
Published: (2020-07-01)

The effect of cholinesterase inhibitors on sleep in the patients with Alzheimer’s disease: an observational prospective study
by: Osman Korucu, et al.
Published: (2018-01-01)